Showlist patient support
Making a difference in Cancer Control
patients raviva-rekanto bis.jpg
relayfor life lux.jpg
ecl pharma recommendations.jpg
The European Action Against Rare Cancers campaign was launched on 24 June 2009. ECL is on the organising committee for the campaign, which urges European policy-makers to prioritise better treatment and care for patients with rare cancers within the framework of the new Commission Communication on cancer and other recent policy initiatives such as the Council Recommendation on Rare Diseases.
February 2014: Consensus was established on how to improve pathologic diagnosis of rare cancers at the 'Rare Cancers Consensus Meeting: Pathology in Rare Cancers', 10–11 February 2014 in Brussels.
For updates and news, visit the Rare Cancers EU website: http://www.rarecancerseurope.org/
ECL is one of the supporting organisations. The Call to Action – an international petition appeals to all stakeholders to initiate targeted actions to address the challenges of rare cancers.
Don’t forget to sign the Call to Action Against Rare Cancers!